Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations
Jiao Xie, Jason A. Roberts, Jeffrey Lipman, Yan Cai, Haitao Wang, Nuan-Nuan Zhao, Xiaona Xu, Shan Yang, Youjia Li, Kanghuai Zhang
Topics & Concepts
MedicinePolymyxin BPharmacodynamicsNephrotoxicityDosingPharmacokineticsPolymyxinPopulationPharmacologyAntibioticsMinimum inhibitory concentrationInternal medicineToxicityMicrobiologyBiologyEnvironmental healthAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyPneumocystis jirovecii pneumonia detection and treatment